- Abstract:
-
Advances in treatments and treatment strategies for PsA have led to many patients responding well to management of their disease, and targeting remission as a treatment goal is now a possibility. Treat to target is a strategy aimed at maximizing benefit, irrespective of the type of medication used, by monitoring disease activity and using it to guide therapy. The measurement of response to treatment has been the subject of wide discussions among experts for some time, and many instruments exi...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted Manuscript
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Rheumatology Journal website
- Volume:
- 57
- Issue:
- 8
- Pages:
- 1321-1331
- Publication date:
- 2017-10-16
- Acceptance date:
- 2017-08-14
- DOI:
- EISSN:
-
1462-0332
- ISSN:
-
1462-0324
- Pubs id:
-
pubs:896153
- URN:
-
uri:92016165-4c97-4f14-b33b-5ec3c68cebd8
- UUID:
-
uuid:92016165-4c97-4f14-b33b-5ec3c68cebd8
- Local pid:
- pubs:896153
- Language:
- English
- Keywords:
- Copyright holder:
- Coates et al.
- Copyright date:
- 2017
- Notes:
-
Copyright © 2017 The Authors. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at: https://doi.org/10.1093/rheumatology/kex344
Journal article
Remission in psoriatic arthritis—where are we now?
Actions
Authors
Funding
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record